Analysts Set CVS Health Corporation (NYSE:CVS) PT at $106.75

CVS Health Corporation (NYSE:CVS) has earned a consensus recommendation of “Moderate Buy” from the twenty-four analysts that are currently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and twenty-two have issued a buy recommendation on the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $107.1667.

Several research firms have commented on CVS. Sanford C. Bernstein raised their price objective on CVS Health from $94.00 to $106.00 and gave the company an “outperform” rating in a research report on Tuesday, May 12th. Robert W. Baird set a $107.00 target price on CVS Health in a research report on Thursday, August 6th. Morgan Stanley increased their target price on CVS Health from $106.00 to $111.00 and gave the company an “overweight” rating in a research note on Thursday, June 4th. Deutsche Bank Aktiengesellschaft raised their target price on CVS Health from $88.00 to $92.00 and gave the company a “buy” rating in a report on Thursday, May 7th. Finally, Weiss Ratings upgraded CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, August 5th.

Institutional Investors Weigh In On CVS Health

Large investors have recently added to or reduced their stakes in the company. Kilter Group LLC purchased a new position in CVS Health in the 2nd quarter valued at about $27,000. Beaird Harris Wealth Management LLC increased its position in shares of CVS Health by 201.0% during the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock worth $30,000 after acquiring an additional 195 shares during the last quarter. J.Safra Asset Management Corp acquired a new position in shares of CVS Health in the second quarter worth about $30,000. Dunhill Financial LLC acquired a new position in shares of CVS Health in the second quarter worth about $32,000. Finally, Swiss RE Ltd. purchased a new position in CVS Health in the fourth quarter valued at about $26,000. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Price Performance

CVS opened at $93.58 on Monday. CVS Health has a 52-week low of $69.51 and a 52-week high of $110.68. The company has a 50 day moving average of $102.32 and a two-hundred day moving average of $88.69. The company has a market cap of $119.68 billion, a P/E ratio of 24.76, a P/E/G ratio of 0.91 and a beta of 0.61. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, beating analysts’ consensus estimates of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. During the same quarter last year, the firm posted $1.81 EPS. The business’s revenue for the quarter was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, analysts expect that CVS Health will post 8.02 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s payout ratio is presently 70.37%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.